AI Article Synopsis

  • A 66-year-old woman was diagnosed with advanced esophageal cancer (stage III) and had significant lymph node spread in her body.
  • She underwent two rounds of a chemotherapy regimen called DCF, which showed promising results by significantly reducing the tumor and affected lymph nodes.
  • After surgery, analysis revealed no residual cancer cells, indicating a complete pathological response to the treatment, suggesting DCF chemotherapy may be very effective for this condition.

Article Abstract

The patient was a 66-year-old woman, who was diagnosed with cT3N3M0, cStage III esophageal cancer with widespread lymph node metastases in the mediastinum and abdomen. She was treated with 2 courses of chemotherapy with docetaxel/ cisplatin/5-FU(DCF therapy). CT and FDG PET-CT showed a significant reduction in both the primary tumor and the metastatic lymph nodes following treatment. We performed subtotal esophagectomy and gastric tube reconstruction with lymphadenectomy. The histopathological findings showed no residual viable tumor cells or foreign body-type giant cells with necrosis. The pathological effect of chemotherapy was defined as Grade 3(pCR). Our case suggested that DCF chemotherapy is potentially a very effective treatment for advanced esophageal cancer with widespread lymph node metastases.

Download full-text PDF

Source

Publication Analysis

Top Keywords

esophageal cancer
12
cancer widespread
12
widespread lymph
12
lymph node
12
node metastases
12
advanced esophageal
8
[pathological complete
4
complete response
4
response case
4
case advanced
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!